Cag AM833 – Advanced Satiety
⚖️ CagriIintide (Cag AM833) – Advanced Satiety Peptide
CagriIintide is a next-generation peptide designed to support appetite regulation and metabolic balance. It mimics the action of amylin, working synergistically with GLP-1 pathways to promote satiety and delay gastric emptying.
-
🔬 Targets amylin and calcitonin receptors
-
🍽️ Supports fullness and appetite control
-
🧪 Studied in weight loss and type 2 diabetes protocols
Benefits
-
Weight management mechanisms
-
Hormonal regulation of hunger
-
Peptide-based metabolic therapies
Suggested Use:
- For scientific research only.
- Not for human consumption.
- 🫶 Cag is often combined with SEMI-G to enhance weight loss.
COAs and a quick definition list for peptides are found as a link at the bottom of our website, or you can click here.
Check out Jay Campbell's website, which is an excellent source for peptide research.
All Peptides we sell are intended for RESEARCH ONLY.
Not for diagnostic, therapeutic, or human use.
Please know that a 3rd party has tested all of our products for purity at least once, and sometimes, we even use a second vendor to ensure the highest quality.
XQ-co, LLC. is not responsible for any negative inflictions arising after you administer products. We will not compensate for products that have been wasted or misused.
